Kathryn Volkening - Search Results

Year	Number of Results
2006	1
2007	2
2008	3
2009	5
2010	1
2011	2
2012	3
2013	3
2014	6
2015	1
2017	2
2018	6
2019	4
2020	4
2021	1
2022	0

1

Alterations in Tau Metabolism in ALS and ALS-FTSD.

Strong MJ, Donison NS, Volkening K. Strong MJ, et al. Among authors: volkening k. Front Neurol. 2020 Nov 23;11:598907. doi: 10.3389/fneur.2020.598907. eCollection 2020. Front Neurol. 2020. PMID: 33329356 Free PMC article. Review.

2

RNA-binding proteins as molecular links between cancer and neurodegeneration.

Campos-Melo D, Droppelmann CA, Volkening K, Strong MJ. Campos-Melo D, et al. Among authors: volkening k. Biogerontology. 2014 Dec;15(6):587-610. doi: 10.1007/s10522-014-9531-2. Epub 2014 Sep 18. Biogerontology. 2014. PMID: 25231915 Review.

3

RNA metabolism in ALS: when normal processes become pathological.

Droppelmann CA, Campos-Melo D, Ishtiaq M, Volkening K, Strong MJ. Droppelmann CA, et al. Among authors: volkening k. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):321-36. doi: 10.3109/21678421.2014.881377. Epub 2014 Feb 20. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24555412 Review.

4

TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?

Strong MJ, Volkening K. Strong MJ, et al. Among authors: volkening k. FEBS J. 2011 Oct;278(19):3569-77. doi: 10.1111/j.1742-4658.2011.08277.x. Epub 2011 Sep 6. FEBS J. 2011. PMID: 21810174 Free article. Review.

5

The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases.

Droppelmann CA, Campos-Melo D, Volkening K, Strong MJ. Droppelmann CA, et al. Among authors: volkening k. Front Cell Neurosci. 2014 Sep 10;8:282. doi: 10.3389/fncel.2014.00282. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25309324 Free PMC article. Review.

6

Evidence of synergism among three genetic variants in a patient with LMNA-related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype.

Volkening K, Farhan SMK, Kao J, Leystra-Lantz C, Ang LC, McIntyre A, Wang J, Hegele RA, Strong MJ. Volkening K, et al. Mol Cell Biochem. 2021 Jul;476(7):2633-2650. doi: 10.1007/s11010-021-04103-7. Epub 2021 Mar 4. Mol Cell Biochem. 2021. PMID: 33661429 Free PMC article.

7

Inclusion Formation and Toxicity of the ALS Protein RGNEF and Its Association with the Microtubule Network.

Di Gregorio SE, Volkening K, Strong MJ, Duennwald ML. Di Gregorio SE, et al. Among authors: volkening k. Int J Mol Sci. 2020 Aug 5;21(16):5597. doi: 10.3390/ijms21165597. Int J Mol Sci. 2020. PMID: 32764283 Free PMC article.

8

Tau protein phosphorylation at Thr¹⁷⁵ initiates fibril formation via accessibility of the N-terminal phosphatase-activating domain.

Hintermayer MA, Volkening K, Moszczynski AJ, Donison N, Strong MJ. Hintermayer MA, et al. Among authors: volkening k. J Neurochem. 2020 Nov;155(3):313-326. doi: 10.1111/jnc.14942. Epub 2019 Dec 30. J Neurochem. 2020. PMID: 31853971 Free article.

9

Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function.

Tétreault M, Deshaies JE, Semmler S, Sidibé H, Shkreta L, Volkening K, Soreq H, Strong MJ, Chabot B, Vande Velde C. Tétreault M, et al. Among authors: volkening k. Brain. 2018 Dec 1;141(12):e84. doi: 10.1093/brain/awy261. Brain. 2018. PMID: 30364932 Free PMC article. No abstract available.

10

Neurofilament Immunohistochemistry Followed by Luxol Fast Blue, for Staining Axons and Myelin in the Same Paraffin Section of Spinal Cord.

Moszczynski AJ, Volkening K, Strong MJ. Moszczynski AJ, et al. Among authors: volkening k. Appl Immunohistochem Mol Morphol. 2020 Aug;28(7):562-565. doi: 10.1097/PAI.0000000000000814. Appl Immunohistochem Mol Morphol. 2020. PMID: 31652146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results